查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1820295

2025 年至 2033 年細胞分離市場規模、佔有率、趨勢及預測（按技術、細胞類型、產品、應用、最終用途和地區）

Cell Isolation Market Size, Share, Trends and Forecast by Technique, Cell Type, Product, Application, End Use, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球細胞分離市場規模達156億美元。展望未來， IMARC Group預計到2033年，市場規模將達到530億美元，2025-2033年期間的複合年成長率（CAGR）為12.99%。目前，北美佔據市場主導地位，2024年的市佔率將超過39.9%。慢性病發病率的上升、對有效分離方法的需求、對再生醫學和細胞療法的需求不斷成長，以及對生物技術和生命科學的投資不斷增加，都是促進市場成長的因素。

再生醫學領域的不斷擴展以及對高效細胞分離技術日益成長的需求影響著全球細胞分離市場的成長。慢性病的日益普及反過來又催生了對先進細胞療法的需求，從而促進了市場的整體成長。因此，生物技術和生命科學領域的更多投資和資金推動了研發活動，進一步增強了市場發展勢頭。個人化醫療需求的不斷成長進一步推動了對特定細胞分離方法的需求，從而推動了市場的成長。對癌症研究的日益重視和對標靶治療的需求也促進了市場的成長。人口老化加劇以及學術機構和產業參與者之間的快速合作進一步推動了市場的發展。

在美國，市場由生物技術和生物製藥研究的重大進展所驅動。個人化醫療和再生療法的需求不斷成長，以及癌症等慢性疾病發病率的上升，推動了對精確細胞分離方法的需求。政府對醫療保健研究的資助，加上私部門的投資，支持了細胞分離技術的創新。此外，癌症和自體免疫疾病中細胞療法和免疫療法的日益普及也推動了市場擴張。領先的製藥和生物技術公司的存在，加上強大的醫療保健基礎設施，也加速了細胞分離技術在臨床和研究環境中的應用。例如，2024年4月，機器人公司Multiply Labs（一家創建行業領先的自動化製造系統以生產定製藥物的公司）和全球頂級生命科學研究工具和服務供應商之一金斯瑞生物科技公司（GenScript）宣佈建立戰略合作夥伴關係，重點是自動化細胞療法製造中的細胞分離階段，以簡化這一耗時的過程。

細胞分離市場趨勢：

再生醫學領域不斷拓展

再生醫學領域的不斷發展與全球細胞分離市場的擴張密切相關。再生醫學強調利用細胞的潛力修復受損的組織和器官，以實現醫療模式的現代化。隨著研究人員對再生醫學的研究，對精確有效的細胞分離方法的需求日益凸顯。分離高純度的特定細胞類型對於確保再生程序的成功至關重要。現代細胞分離技術的開發和應用正是為滿足這一需求而開發的，這推動了市場的成長。全球相關機構正在製定政策和方案，以進一步推動該領域的發展。例如，美國政府責任署（USGAO）提出了11項政策提案，旨在幫助解決再生醫學面臨的問題或提升其優勢。

慢性病盛行率上升

慢性病的日益普及引發了對先進細胞療法的迫切需求，從而推動了細胞分離市場的顯著成長。糖尿病、心血管疾病和神經退化性疾病等慢性疾病為世界各地的醫療保健系統帶來了重大挑戰。根據美國衛生與公共服務部的數據，估計有1.29億美國人至少有一種嚴重的慢性疾病，例如癌症、糖尿病、高血壓、心臟病和肥胖症。患有多種慢性疾病的美國人數量正在上升；42%的人患有兩種或兩種以上，12%的人至少患有五種。慢性疾病除了對個人造成損害外，還對美國醫療保健系統產生了重大影響。每年4.1兆美元的醫療支出中，約90%用於治療和管理精神健康問題和慢性疾病。細胞療法透過提供再生和個人化的治療方法，在解決這些問題方面具有巨大的潛力。為了充分發揮此類療法的潛力，分離出具有活力且功能完整的細胞至關重要。這項需求促使人們加強研發力度，創新高效的細胞分離方法，滿足細胞治療的多樣化需求，進而塑造市場的發展軌跡。

生物技術和生命科學領域的資金和投資

生物技術和生命科學領域的雄厚資金和發展推動著細胞分離市場不斷成長。過去三年，全球生技產業的創投 (VC) 資金激增。例如，根據印度投資網的資料，光是印度在生技領域就有 15 個投資項目，總額達 371 萬美元。私人投資者、政府和創投家都了解細胞分離技術的革命性進步可以用於各種用途，例如藥物開發和疾病治療。因此，大量的資金投入到旨在開發和改進細胞分離技術的研究計畫中。這些資金的流入可以進一步開發新方法，並促進先進細胞分離產品的商業化。科學研究和金融投資相結合推動市場向前發展，使其處於技術和醫療創新的前沿。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球細胞分離市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依技術

  • 離心
  • 表面標記
  • 濾

第7章：市場區隔：依電池類型

  • 人類細胞
  • 動物細胞

第8章：市場區隔：依產品

  • 耗材
    • 關鍵部分
      • 試劑、試劑盒、培養基及血清
      • 珠
      • 免洗用品
  • 儀器
    • 關鍵部分
      • 離心機
      • 流式細胞儀
      • 過濾系統
      • 磁激活細胞分離系統

第9章：市場區隔：依應用

  • 生物分子分離
  • 療法
  • 幹細胞研究
  • 癌症研究
  • 組織再生
  • 體外診斷

第 10 章：市場區隔：最終用途別

  • 生物技術和生物製藥公司
  • 醫院和診斷實驗室
  • 研究實驗室和研究所
  • 其他

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 12 章：SWOT 分析

第 13 章：價值鏈分析

第 14 章：波特五力分析

第 15 章：價格分析

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Alfa Laval AB
    • Becton Dickinson and Company
    • Beckman Coulter Inc. (Danaher Corporation)
    • Bio-Rad Laboratories Inc.
    • General Electric Company
    • Merck KGaA
    • Miltenyi Biotec BV & Co. KG
    • pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
    • Roche Holding AG
    • STEMCELL Technologies Inc.
    • Terumo Corporation
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A3942

The global cell isolation market size reached USD 15.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 53.0 Billion by 2033, exhibiting a growth rate (CAGR) of 12.99% during 2025-2033. North America, currently dominates the market, holding a market share of over 39.9% in 2024. An increase in chronic illnesses, the necessity for effective isolation methods, the rising demand for regenerative medicine and cell-based therapies, and rising investments in biotechnology and life sciences are factors facilitating the market growth.

The expanding field of regenerative medicine and the escalating need for efficient cell isolation techniques influence the global cell isolation market growth. The increasing prevalence of chronic diseases in turn creates a demand for advanced cell-based therapies, promoting the market's overall growth. Consequently, more investment and funding in the biotechnology and life sciences segments fuel research and development (R&D) activities, which further increase the market momentum. The increasing demand for personalized medicine, further boosts the requirement for specific cell isolation methods, thus propelling the market growth. The rising emphasis on cancer research and the demand for targeted therapies are contributing to the market growth. The market is further driven by the increasing aging population base and rapid collaborations between academic institutions and industry players.

In the United States, the market is driven by significant advancements in biotechnology and biopharmaceutical research. An increased demand for personalized medicine and regenerative therapies, along with rising incidences of chronic diseases like cancer, boosts the need for precise cell isolation methods. Government funding for healthcare research, coupled with private sector investments, supports innovation in cell isolation technologies. Furthermore, the growing trend toward cell-based therapies and immunotherapies in cancer and autoimmune diseases is fueling market expansion. The presence of leading pharmaceutical and biotechnology companies, along with robust healthcare infrastructure, also accelerates the adoption of cell isolation technologies in clinical and research settings. For instance, in April 2024, Multiply Labs, a robotics company creating industry-leading automated manufacturing systems to produce customized drugs, and GenScript Biotech Corporation (GenScript), one of the world's top suppliers of life-science research tools and services, announced a strategic partnership centered on automating the cell isolation phase of cell therapy manufacturing to simplify this time-consuming procedure.

Cell Isolation Market Trends:

Expanding Field of Regenerative Medicine

The expanding field of regenerative medicine is closely related to the expansion of the worldwide cell isolation market. Regenerative medicine highlights employing the potential of cells to repair broken tissues and organs, thereby modernizing medical treatment paradigms. The need for accurate and effective cell separation methods is becoming more and more clear as researchers investigate regenerative medicines. Isolation of specialised cell types with high purity is vital to guarantee the accomplishment of regenerative procedures. Modern cell separation technologies are developed and adopted in response to this demand, which fuels market growth. Concerning bodies across the globe are making policies and schemes to further advance the field. For instance, 11 policy proposals were created by the US Government Accountability Office to help address the issues or improve the advantages of regenerative medicine.

Rising Prevalence of Chronic Diseases

The escalating prevalence of chronic diseases has ignited a pressing need for advanced cell-based therapies, thereby driving significant growth in the cell isolation market. Chronic diseases like diabetes, cardiovascular disease, and neurodegenerative disorders present significant obstacles for healthcare systems around the world. According to the US Department of Health and Human Services, an estimated 129 Million Americans endure at least one severe chronic illness, such as cancer, diabetes, hypertension, heart disease, and obesity. The number of Americans living with numerous chronic illnesses is rising; 42% have two or more, and 12% have at least five. Chronic illness has a significant influence on the US health care system in addition to its personal toll. Approximately 90% of the USD 4.1 Trillion spent on health care each year goes towards treating and managing mental health issues and chronic illnesses. Cell-based therapies secure massive potential in addressing these tasks by offering regenerative and personalized treatment methods. In order to harness the potential of such therapies, the isolation of viable and functionally intact cells is vital. This imperative has led to intensified research and development efforts to innovate efficient cell isolation methods that cater to the diverse needs of cell-based treatments, shaping the trajectory of the market.

Funding and Investments in Biotechnology and Life Sciences Sectors

Strong funding and developments in the biotechnology and life sciences sectors are driving the market for cell isolation upward. The biotechnology industry across the globe has seen a surge in venture capital (VC) funding during the last three years. For instance, as per the data by Indian Investment Grid, India alone has 15 investment projects totalling USD 3.71 Million in the biotechnology subsector. Private investors, governments, and venture capitalists understand how revolutionary advances in cell separation techniques can be for various uses, such as medication development and illness treatment. Thus, significant financial funds into research initiatives directed towards developing and improving the technologies of cell isolation. Such an inflow of money can further develop new methods, as well as lead to the commercialization of advanced cell isolation products. The market is driven forward by the combination of scientific research and financial investments, placing it at the forefront of technical and medical innovation.

Cell Isolation Industry Segmentation:

Analysis by Technique:

  • Centrifugation
  • Surface Marker
  • Filtration

Centrifugation leads the market with around 43.8% of market share in 2024. Important factors supporting the expansion of the centrifugation segment include rising awareness of the diversity of centrifugation procedures, which may isolate a variety of cell types, from subcellular organelles to blood components. Technological improvements in centrifuges, resulting in faster processing and better separation efficiency, also continue to support their wide adoption. The proven reliability and ease of use ensure that the method finds favor with an extensive user base of researchers and clinicians. Centrifugation further meets compatibility standards with the varying sample sizes and volumes, thus being flexible enough to provide for a multitude of experimental needs. Its compatibility with numerous sample sources, such as blood, tissues, and cell cultures, situates centrifugation as a versatile and significant technique in cell isolation workflows, driving its segment growth within the broader market landscape.

Analysis by Cell Type:

  • Human Cells
  • Animal Cells

Animal cells leads the market with around 53.7% of market share in 2024. The growing use of animal cells in drug development and scientific research is the main factor driving the expansion of animal cell isolation. The increasing demand for effective separation techniques has also been driven by the need for biopharmaceuticals, increasingly using animal cell cultures for production. The increasing regenerative medicine use encourages the investigation of treatments relying on animal cells and requires optimized protocols for isolation. Furthermore, the increase in chronic diseases requires advanced disease modeling utilizing animal cells, further driving the segment's growth. Technological developments in cell isolation techniques support market growth by meeting the complex needs of animal cell isolation. Partnerships between academic institutions and industry players enable knowledge discussion, thereby contributing to innovative resolutions in this segment.

Analysis by Product:

  • Consumables
    • Reagents, Kits, Media and Sera
    • Beads
    • Disposables
  • Instruments
    • Centrifuges
    • Flow Cytometers
    • Filtration Systems
    • Magnetic-activated Cell Separator Systems

Consumables lead the market with around 62.2% of market share in 2024. The consumables segment in the market is driven by the increasing adoption of cell-based therapies and regenerative medicine leading to a boost in demand for consumable products for cell isolation procedures. The demand for effective and reliable consumables including reagents, kits, and disposables is growing as clinicians and researchers endeavor to channel the potential of cell therapies. The increasing incidences of chronic conditions have emphasized personalized medicine and precision treatment, compelling specific consumables for isolating target cell populations. Advances in consumable technologies such as better labeling and tagging agents have improved the efficiency and precision of cell isolation. Furthermore, collaborations between research institutions and consumable manufacturers have driven innovation, leading to the development of specialized products tailored to diverse research needs.

Analysis by Application:

  • Biomolecule Isolation
  • Therapeutics
  • Stem Cell Research
  • Cancer Research
  • Tissue Regeneration
  • In-Vitro Diagnostics

Biomolecule isolation leads the market with around 38.7% of the market share in 2024. The major driver for the increase in this segment is the growing field of proteomic and genomic research. The need to extract biomolecules for diagnosis and treatment is increasing because of the growing interest in personalized medicine. Furthermore, biomolecule isolation has become a prerequisite for drug discovery and development of pharmaceutical and biotechnology companies. Technological advancements, particularly in automation and microfluidics, enhance the efficiency and scalability of isolation methods, further driving market growth. Partnerships and collaborations among market players and academic institutions create a knowledge exchange for innovative isolation solutions. This provides impetus to segmental growth as much from rising demand for biomolecules for research applications as it does from the biopharmaceutical industry.

Analysis by End Use:

  • Biotechnology and Biopharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Research Laboratories and Institutes
  • Others

Research laboratories and institutes lead the market with around 49.2% of the market share in 2024. The growth of the research laboratories and institutes segment is boosted by the increasing landscape of scientific discovery, which has pushed the demand for cutting-edge tools. Additionally, the growing emphasis on improvements in the biological sciences and healthcare fields calls for effective cell isolation methods, which is propelling market expansion. Partnerships between academia and industry strengthen research capabilities, encouraging the need for high-quality cell isolation tools. In line with this, rising funding and grants focus sources toward research institutions, aiding investment in advanced isolation methodologies. Additionally, the vigorous nature of research demands flexible solutions, boosting the uptake of customizable cell isolation products. Furthermore, the continuous evolution of drug discovery and development deepens the dependence on robust cell isolation for accurate experimentation.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 39.9%. The region's strong healthcare system and significant research investment are the main drivers of North America's cell isolation market expansion. Furthermore, the need for precise cell-based treatments is fueled by the rise of chronic illnesses like diabetes and cardiovascular conditions, which encourages the use of effective isolation techniques. In line with this, the presence of major biotechnology and pharmaceutical players, coupled with strong research partnerships between academia and industry, promotes technological innovation. Additionally, research and development activities are supported by significant funding from both public and private organizations, which encourages the market's growth. Aside from this, the need of accurate cell separation is increased by North America's growing emphasis on personalized medicine and regenerative medicines. North America's dominant position in the global market is further enhanced by the region's regulatory framework and strict quality standards, which foster the commercialization of cutting-edge cell isolation products.

Key Regional Takeaways:

United States Cell Isolation Market Analysis

Improvements in biomedical research and the rising need for personalised therapy are driving the US cell isolation market. With the help of organisations like the National Institutes of Health (NIH), which gave out nearly USD 47 Billion in research grants in 2023, the United States is at the forefront of life sciences innovation. The use of cell therapy, especially CAR-T therapies, to treat illnesses like cancer has grown in popularity, thereby increasing the need for effective cell isolation technologies. Since isolated cells are essential for creating regenerative therapies, the market is also growing because of an increase in chronic diseases including diabetes and autoimmune disorders. With more than 20,000 current studies involving cell isolation technologies, the increasing prevalence of clinical trials suggests increased market activity. Additionally, the necessity for sophisticated cell processing techniques is highlighted by the growth of biosciences in the country. According to data from the Biotechnology Innovation Organization, the biosciences sector's overall economic impact on the US economy in 2021, as determined by total output, was USD 2.9 trillion. The United States also has a strong network of academic and research institutions, which promotes innovation in cell separation methods like magnetic-activated cell sorting (MACS) and microfluidics. Market expansion is further accelerated by the Food and Drug Administration's support for cell-based therapies and regenerative medicine. This is furthered with the creation of innovative cell separation solutions by businesses like BD Biosciences and Thermo Fisher Scientific, which, in turn, is contributing to the market growth.

Europe Cell Isolation Market Analysis

The growing frequency of infectious and chronic diseases, along with rising investments in healthcare innovation, are driving the cell isolation market in Europe. The use of cell isolation methods is accelerated by the substantial funding of biomedical research provided by the European Union's Horizon Europe initiative, which has a Euro 95.5 Billion (USD 100 Billion) budget (2021-2027). The market is growing because of the region's emphasis on cell-based treatments for neurological illnesses and cancer. France, Italy, and Germany are leading centers with a significant number of stem-cell transplants. According to data from the European Union, Germany had the highest rate of stem cell transplants among EU members in 2018 (9.6 per 100,000 population), closely followed by Italy (9.4). The Netherlands (8.4; 2017 statistics), Belgium (8.4), Sweden (8.2), and France (8.6 per 100,000 population) came next. The market expansion is also supported by regulatory frameworks that support advanced therapeutics, such as the Advanced Therapy Medicinal Products (ATMP) classification system established by the European Medicines Agency. Furthermore, the need for cell-based diagnostics and therapies is fuelled by Europe's ageing population, which is expected to account for 28% of the continent's total population by 2030.

Asia Pacific Cell Isolation Market Analysis

A major market for cell isolation is developing in Asia-Pacific as a result of rising healthcare spending and an increased emphasis on regenerative medicine. China and India are significant contributors; the biotechnology sector in China is expanding at a rate of more than 15% per year, as per an industrial report. Government initiatives such as the "Made in China 2025" plan showcase advancements in biopharmaceuticals and cellular therapies. Japan is also at the forefront, with approved induced pluripotent stem cell (iPSC)-based treatments, which has raised demand for cell isolation. In line with this, the Biotechnology Industry Research Assistance Council (BIRAC), a non-profit Section 8, Schedule B, Public Sector Enterprise established by the Department of Biotechnology (DBT), Government of India, has a flagship program called the "Biotechnology Ignition Grant Scheme (BIG)" that identifies and funds innovative ideas in the biotech industry, further augmenting the research in this field. Market expansion is further accelerated by the region's growing interest in precision medicine and the rising incidence of infectious diseases. Cell isolation methods are also more widely available due to the region's economic production of consumables and reagents.

Latin America Cell Isolation Market Analysis

Growing research into infectious diseases like dengue and Zika is driving the demand for cell isolation in Latin America. With the help of government programs to improve the infrastructure for biomedical research, Brazil and Mexico are the leaders in the region. Cell isolation technologies are becoming more and more popular, partly due to the growth of biobanks and stem cell research initiatives, particularly in Brazil. International partnerships with research institutes in North America and Europe have also made cutting-edge technologies more accessible. Opportunities for cell-based therapeutics that target chronic diseases like diabetes and cardiovascular ailments are created by the region's growing healthcare market. As per the data by International Trade Administration, Brazil is the largest healthcare market in Latin America and spends 9.47% of its GDP on healthcare, which represents USD 161 Billion.

Middle East and Africa Cell Isolation Market Analysis

The rising prevalence of chronic illnesses and infectious disorders is driving growth in the Middle East and Africa (MEA) cell isolation market. In the MENA region, cardiovascular diseases-which include heart disease and stroke-are the main cause of death. According to the Global Burden of Disease Study, over 810,000 people died from ischemic heart disease and over 370,000 from stroke in the region in 2019. In the MENA region, cancer is becoming a bigger concern. It was projected that the region will see approximately 274,000 cancer-related fatalities and almost 461,000 new cancer cases in 2020. Breast, lung, colorectal, and prostate cancers were the most common types. Respiratory diseases, including chronic obstructive pulmonary disease (COPD) and asthma, are prevalent in MENA. COPD itself reported for approximately 3.2 million disability-adjusted life years (DALYs) lost in 2019. To solve healthcare issues, nations like the UAE and South Africa are investing in biotechnology and regenerative medicine. The use of cell isolation techniques is increasing because of partnerships with international research organisations and projects to build cutting-edge labs. The industry is expanding due to developments in immunotherapy and the increased emphasis on stem cell banking. The market's steady growth in the area is further facilitated by investments in healthcare infrastructure and encouraging government initiatives.

Competitive Landscape:

The cell isolation market's competitive environment is characterized by dynamic elements that influence industry dynamics. Intense research and development (R&D) activities ensure continuous innovation that results in the introduction of the latest cell isolation technologies. Market players aim to broaden their product portfolios offering a range of isolation solutions ranging from various cell types and applications. Partnerships among industry and academia promote collaborative advancement towards technological breakthroughs. Regulatory compliance and quality standards remain pivotal in this landscape, influencing market entry and expansion strategies. As the landscape evolves, there is also a growing focus on automation and the incorporation of cutting-edge methods to increase isolation repeatability and efficiency. As the market gains traction due to rising medical needs and scientific developments, competition deepens, facilitating players to distinguish through product efficacy, reliability, and versatility while striving to address the ever-evolving demands of the research and healthcare industries.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Alfa Laval AB
  • Becton Dickinson and Company
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-Rad Laboratories Inc.
  • General Electric Company
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
  • Roche Holding AG
  • STEMCELL Technologies Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What is cell isolation?
  • 2.How big is the cell isolation market?
  • 3.What is the expected growth rate of the global cell isolation market during 2025-2033?
  • 4.What are the key factors driving the global cell isolation market?
  • 5.What is the leading segment of the global cell isolation market based on the technique?
  • 6.What is the leading segment of the global cell isolation market based on cell type?
  • 7.What is the leading segment of the global cell isolation market based on product?
  • 8.What is the leading segment of the global cell isolation market based on application?
  • 9.What is the leading segment of the global cell isolation market based on end use?
  • 10.What are the key regions in the global cell isolation market?
  • 11.Who are the key players/companies in the global cell isolation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell Isolation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technique

  • 6.1 Centrifugation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Surface Marker
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Filtration
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Cell Type

  • 7.1 Human Cells
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Animal Cells
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Product

  • 8.1 Consumables
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Reagents, Kits, Media and Sera
      • 8.1.2.2 Beads
      • 8.1.2.3 Disposables
    • 8.1.3 Market Forecast
  • 8.2 Instruments
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Centrifuges
      • 8.2.2.2 Flow Cytometers
      • 8.2.2.3 Filtration Systems
      • 8.2.2.4 Magnetic-activated Cell Separator Systems
    • 8.2.3 Market Forecast

9 Market Breakup by Application

  • 9.1 Biomolecule Isolation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Therapeutics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Stem Cell Research
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cancer Research
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Tissue Regeneration
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 In-Vitro Diagnostics
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10 Market Breakup by End Use

  • 10.1 Biotechnology and Biopharmaceutical Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Diagnostic Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research Laboratories and Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Alfa Laval AB
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 General Electric Company
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Merck KGaA
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Miltenyi Biotec B.V. & Co. KG
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Roche Holding AG
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 STEMCELL Technologies Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Terumo Corporation
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Thermo Fisher Scientific Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Cell Isolation Market: Major Drivers and Challenges
  • Figure 2: Global: Cell Isolation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cell Isolation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Cell Isolation Market: Breakup by Technique (in %), 2024
  • Figure 5: Global: Cell Isolation Market: Breakup by Cell Type (in %), 2024
  • Figure 6: Global: Cell Isolation Market: Breakup by Product (in %), 2024
  • Figure 7: Global: Cell Isolation Market: Breakup by Application (in %), 2024
  • Figure 8: Global: Cell Isolation Market: Breakup by End Use (in %), 2024
  • Figure 9: Global: Cell Isolation Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Cell Isolation (Centrifugation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Cell Isolation (Centrifugation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Cell Isolation (Surface Marker) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Cell Isolation (Surface Marker) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Cell Isolation (Filtration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Cell Isolation (Filtration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Cell Isolation (Human Cells) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Cell Isolation (Human Cells) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Cell Isolation (Animal Cells) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Cell Isolation (Animal Cells) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Cell Isolation (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Cell Isolation (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Cell Isolation (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Cell Isolation (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Cell Isolation (Biomolecule Isolation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Cell Isolation (Biomolecule Isolation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Cell Isolation (Therapeutics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Cell Isolation (Therapeutics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Cell Isolation (Stem Cell Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Cell Isolation (Stem Cell Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Cell Isolation (Cancer Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Cell Isolation (Cancer Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Cell Isolation (Tissue Regeneration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Cell Isolation (Tissue Regeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Cell Isolation (In-Vitro Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Cell Isolation (In-Vitro Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Cell Isolation (Biotechnology and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Cell Isolation (Biotechnology and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Cell Isolation (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Cell Isolation (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Cell Isolation (Research Laboratories and Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Cell Isolation (Research Laboratories and Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Cell Isolation (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Cell Isolation (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: North America: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: North America: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: United States: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: United States: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Canada: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Canada: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Asia-Pacific: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Asia-Pacific: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: China: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: China: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Japan: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Japan: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: India: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: India: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: South Korea: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: South Korea: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Australia: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Australia: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Indonesia: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Indonesia: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Europe: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Europe: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Germany: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Germany: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: France: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: France: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: United Kingdom: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: United Kingdom: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Italy: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Italy: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Spain: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Spain: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Russia: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Russia: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Latin America: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Latin America: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Brazil: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Brazil: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Mexico: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Mexico: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Others: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Others: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Middle East and Africa: Cell Isolation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Middle East and Africa: Cell Isolation Market: Breakup by Country (in %), 2024
  • Figure 92: Middle East and Africa: Cell Isolation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Global: Cell Isolation Industry: SWOT Analysis
  • Figure 94: Global: Cell Isolation Industry: Value Chain Analysis
  • Figure 95: Global: Cell Isolation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cell Isolation Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cell Isolation Market Forecast: Breakup by Technique (in Million USD), 2025-2033
  • Table 3: Global: Cell Isolation Market Forecast: Breakup by Cell Type (in Million USD), 2025-2033
  • Table 4: Global: Cell Isolation Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 5: Global: Cell Isolation Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Cell Isolation Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 7: Global: Cell Isolation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Cell Isolation Market: Competitive Structure
  • Table 9: Global: Cell Isolation Market: Key Players